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Abstract 
The global burden of disease attributable to externalising disorders such as alcohol misuse 
calls urgently for effective prevention and intervention. As our current knowledge is mainly 
derived from high-income countries such in Europe and North-America, it is difficult to 
address the wider socio-cultural, psychosocial context, and genetic factors in which risk and 
resilience are embedded in low- and medium-income countries. c-VEDA was established as 
the first and largest India-based multi-site cohort investigating the vulnerabilities for the 
development of externalising disorders, addictions, and other mental health problems. Using 
a harmonised data collection plan coordinated with multiple cohorts in China, USA, and 
Europe, baseline data were collected from 7 study sites between November 2016 and May 
2019. 9010 participants between the ages of 6 and 23 were assessed during this time, amongst 
which 1278 participants underwent more intensive assessments including MRI scans. Both 
waves of follow-ups have started according to the accelerated cohort structure with planned 
missingness design. Here we present descriptive statistics on several key domains of 
assessments, and the full baseline dataset will be made accessible for researchers outside the 
consortium in September 2019. More details can be found on our website [cveda.org]. 
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The need to investigate mechanisms underlying psychopathology in Low- and Medium-
Income Countries (LMIC) 
The simultaneous acquisition of data measuring behaviour, brain, biology and 
environment during critical neuro-developmental periods has advanced our knowledge of 
individual differences in psychiatric vulnerabilities (1-8), which provides important 
implications in psychiatric nosology and precision psychiatry, for better diagnosis, 
intervention, and prevention (8, 9). In High Income Countries (HIC), several such initiatives 
incorporating large sample sizes with longitudinal design and extensive data sharing have 
been undertaken (9, 10). Standing in contrast is the relatively few such investigations in 
LMIC such as India. However, the non-shared/unique genetic make-ups, distinct 
environmental risk constellations, and unique cultural variables that’s specific to LMIC may 
give rise to mechanisms of psychopathology that are distinct from those in HIC, for example 
gene and environment may present different constitution in psychiatric aetiology in LMIC, or 
gene environment interaction may have different impact on outcomes, moreover, certain 
cultural variables (e.g., religion) may result in differential phenotypical representation of 
biological predispositions.  
The Consortium on Vulnerability to Externalizing Disorders and Addictions (c-
VEDA) was established to address this major gap. With a focus on the development of 
externalising disorders and addictions in adolescence, c-VEDA is the first and largest 
longitudinal study in India that provides a comprehensive characterisation of behaviour and 
psychopathology, cognition, brain structure and function, the environment, and genomics; it 
also contributes to the Global Imaging Genetics Initiative in Adolescence (GIGA), a global 
imaging-genetics consortium that harmonises information across several cohorts by linking 
genetic, brain, behavioural, and remote sensing satellite data to capture determinants of the 
physical environment such as urbanisation, pollution, and climate, that may affect mental 
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health outcomes in children and adolescents across cultures, environments, and ethnic groups 
(9).  
Externalising disorders such as alcohol abuse and dependence contribute substantially 
to the global burden of disease, and the situation is particularly concerning in LMIC. For 
example, globally, 10% of mortality between the ages of 15-49 years is attributable to alcohol 
use (11). While alcohol consumption decreased in recent years in HIC, it is increasing in 
LMIC, such as India (12), where alcohol-attributable mortality is almost twice the rate of 
HIC (13). Studies in HIC have identified both environmental (e.g., stressful life events (19), 
childhood abuse (20)) and genetic factors (e.g., 14-18) that convey risk and resilience for 
externalizing psychopathology. However, with little evidence from LMIC, it is difficult to 
establish if environmental and genomic risk factors are similar or distinct in industrialised 
nations and emerging societies (21). Conducting longitudinal imaging-genetics investigations 
in LMIC and compare with HIC, can help unravel the complex relationships amongst genetic 
and neurobiological factors that are socio-cultural-ethnic specific/relevant in externalising 
psychopathology. 
India is in a unique position to tackle many of these scientific challenges. In addition 
to its distinct genetic make-ups, India has also reported relatively high prevalence rate of 
externalizing problems. Epidemiological studies found that 15.5% school population reported 
having externalising disorders (22), 30-35% men and 5% women consume alcohol (23), and 
the disease burden of externalizing disorders such as alcohol and drug use disorders is 
estimated to be increased by 25% by 2025 (24). Moreover, rapid economic growth in India 
has created changes in socio-economic conditions which include nutritional stress (25, 26), 
pollution (27), widespread socio-economic inequality and vast urbanisation, which are less 
common in HIC. These environmental risk factors specific to India and other emerging 
societies may influence trajectories leading to externalising disorders and substance misuse 
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during childhood and adolescence. As preventive efforts and early interventions mitigate the 
effects of problems and can be the most cost-effective (28), identifying these trajectories is of 
particular relevance for public health and prevention. 
Description of the c-VEDA cohort 
Supported by the Indian Council of Medical Research and the Medical Research 
Council UK, c-VEDA was established in 2015 as a collaborative effort from 7 Indian (Figure 
1) and 3 UK research institutions (King’s College London, Imperial College, and University 
of Bristol). There are three major objectives: (i) to enable investigations into the aetiology 
and life course of externalising disorders by characterising individuals on a great variety of 
environmental factors (exposome), biological characteristics, and brain structure and function, 
(Table 1); (ii) to enable comparative analysis of behavioural trajectories in childhood and 
adolescence across multiple cohorts by sharing a set of core assessments (Table 1) as well as 
data acquisition protocols. This sustainable platform includes cohorts from countries such as 
China (9) and USA (ABCD study; 36) but more specifically with three European cohorts: 
IMAGEN (29), the study of cognition, adolescents and mobile phones (SCAMP) (30), and 
the Avon Longitudinal Study of Parents and Children (ALSPAC) (31, Supplementary 
Material). Together these  cohorts maximised comparability with c-VEDA on genomics, 
neuroimaging, and behavioural data across a wide range of age, e.g., SCAMP’s large 
proportion of participants with south Asian ethnic origin grew up in the UK may enable 
better differentiation between ethnic/genetic effects and environmental factors; (iii) to 
generate a large dataset of individuals at baseline within a relatively short period of time 
using a combination of accelerated longitudinal design (32) and  planned missing data 
design (33). In specific, we recruited participants within a wide age range (6-23 years old) at 
baseline, and randomly assigned them to either of the 2 follow-ups, 1 (Follow-up I) or 2 years 
(Follow-up II) after their baseline assessment (Figure 1b). This approach permitted us to 
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efficiently collect three waves of data that spans a long important developmental period while 
simultaneously reducing the cost of measurement, and increasing compliance by reducing 
fatigue from respondents, thus reducing the number of missing data. The study protocol was 
approved by the ethics committees of the National Institute of Mental Health and 
Neuroscience (NIMHANS) in Bengaluru, India (Item No. VII, SI. No. 7.08, Behavioural 
Sciences) and all regional collaborating institutions. The Indo-UK collaboration was 
approved by the Health Ministry Screening Committee of the Ministry of Health and Family 
Welfare, Government of India. The study was conducted in accordance with the Declaration 
of Helsinki (1964 and later versions).  
Nine thousand and ten participants were recruited between November 2016 and May 
2019 from 7 data acquisition sites in 5 geographical regions (Figure 1a). To account for the 
different socio-cultural and geographical backgrounds, we effortfully recruited participants (1) 
from both urban and rural areas with an agricultural as well as industrial environment (e.g., 
coal mining community in Kolkata, rural villages near Kolkata, Imphal, and Rishi Valley), (2) 
with familial risk for externalizing disorders and addictions (i.e., children of patients with 
psychiatric diagnosis such as substance use disorders through addiction outpatient units in 
Bengaluru-NIMHANS and Chandigarh), and (3) with environmental risks such as toxic 
exposures (coal mines, indoor and outdoor smoke), poor socio-economic status (slum-
dwellers near Bengaluru-NIMHANS), and insurgency and inter-ethnic violence (e.g., 
politically conflicted area near Imphal) (Figure 1a). Two to five recruiters per site 
approached participants, and research purposes and involvement were explained to both the 
parent(s) and child/adolescent. Informed consent was obtained from parents of those under 18 
(assent forms from participants), and participants over the age of 18. Potential participants 
were excluded if they (1) exceed the 3 recruitment age bands (C1: 6-11 years old; C2: 12-17 
years old; C3: 18-23 years old), (2) have extreme physical or mental disability preventing 
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participation; (3) are blind and/or deaf; (4) have any siblings already enrolled in the study, 
and (5) have difficulties (e.g., too far from data acquisition centres) or not willing to attend 
follow-up assessments. Six of the seven sites each recruited a random subsample (total 
N=1278) for neuroimaging data acquisition using resting state functional magnetic resonance 
imaging (rsfMRI), diffusion tensor imaging (DTI) and structural MRI (sMRI).  
While neuroimaging and genotyping data will be made available in February 2020 
(Appendix 1),  behavioural data was published on the IMAGEN databank on 26th June 2019 
(DOI: 10.25720/veda-c13h). Overall and site-specific descriptive is presented in Table 2. Of 
the 9010 participants, 47.8% were boys. Our sample covered a wide range of social class 
(Caste) and religion: just under half (42.8%) were from the general class (a social group that 
do not qualify for reservation benefits and other affirmative action schemes operated by the 
government of India), and 68.3% were Hindu. The majority (68.7%) of participants lived in 
family-owned houses, and a larger proportion lived in urban areas (54.9%) relative to rural 
areas (38.3%). Across sites, majority of the participants were from nuclear families (72.2%). 
Lifetime school enrolment rate was 86.8% (Table 2). Demographics across sites showed 
similar patterns with expected deviations due to the planned recruitment strategies (Table 2). 
According to the planned missingness design described above, all baseline 
participants were randomised into two groups (FU-I, FU-II) based on their age, gender, data 
acquisition site, date of baseline assessment, and MRI participation. Risk groups (e.g., 
familial psychopathology, adverse experiences) were not taken into account in randomisation 
because they were not considered as confounding factor, but rather key determinants for 
phenotypes of investigation. Python script used for randomisation can be found at 
https://github.com/cveda/cveda_databank/tree/master/follow_up. Participants in each group 
were invited to attend a telephone assessment one (FU-I) or two years (FU-II) post baseline 
assessments. Additionally, the neuroimaging subsample were invited to institution-based 
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assessments using a more extensive assessment battery, alongside MRI scans using the same 
Standard Operation Procedure (SOP) as baseline (Table 1).  
FU-I started in November 2017 and FU-II in November 2018. While noting that both 
waves of follow-ups are still on-going and follow-up rates will change with time, as of June 
2019, overall 82.7% (n=2322) from the FU-I group and 68.8% (n=708) from the FU-II group 
have completed their follow up assessments by telephone.  
Description of assessments used in c-VEDA 
A detailed list of assessments is outlined in Table 1. Wherever possible we used 
instruments that have been validated across the age groups. All assessments were translated 
in regionally appropriate languages, and administered using Psytools 
(https://www.delosis.com/psytools/overview.html).  
Environmental measures. We assessed social, familial, and interpersonal 
environment, which included self-reported psychosocial stressors, family violence, social 
discrimination, ownership of assets, distance from main road, food security, nutrition and 
exposure to environmental toxins, and biomass energy use. We have also collected data on 
migration status and addresses of previous residences, from which remote sensing satellite 
data can be linked. Other early environmental exposures such as complications during 
pregnancy and nutrition were also recorded.  
Neuroimaging. The neuroimaging subsample was recruited from 6 (out of 7) sites 
and scanned in 4 scanning centres using five 3T MRI scanners (Figure 1-a). The scanning 
parameters and sequences used in rsfMRI, DTI and sMRI scans can be found in 
https://cveda.org/standard-operating-procedures/. These were designed to match those in 
IMAGEN, with minor updates to allow for changes in technology over time (e.g., Phase 
Encoding polarity techniques for DTI). After the MRI sequences had been frozen, a reference 
dataset had been chosen for each scanner, and reference parameters extracted from its 
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DICOM files. Data acquired from each site were all uploaded to a central database after on-
site quality control (QC) involving script-based assessment of protocol compliance and 
artefact profiling. An independent team then compared meta-data in DICOM files of new 
datasets to the meta-data of the reference dataset to screen for significant deviation bi-weekly, 
visual inspection of image quality were also performed during this process. Prior to each data 
release standardised pre-processing was also applied. Detailed QC and pre-processing SOP 
can be found in each data release alongside imaging data. 
Genomics. Standardised acquisition of whole blood was carried out in all participants 
at baseline, and for the deep phenotyping subsample during in-person follow-ups. All 
biological materials (plasma, buffy coat, red cells, tempus blood) were processed 
immediately after acquisition and stored locally short-term, before being transferred and 
stored long-term centrally at NIMHANS. This biobank allows for DNA and RNA extraction, 
as well as analysis of proteomic and metabolomics. Blood was chosen for its stability for 
DNA and RNA extract over long period of time, as well as its suitability for multimodal-
omics analyses (e.g., genotype, methylation, gene expression), as well as the comparability of 
results derived from peripheral blood with other studies investigating behavioural-omics. 
Acquisition protocols (SOP), including amounts of blood drawn were adapted for each age 
group can be found in Appendix 2.  
Neurotoxins. Plasma and urine samples were collected for analysis of environmental 
neurotoxins (See Appendix 2 for SOP), in particular plasma lead and urinary arsenic, 
cotinine (tobacco metabolite) and metabolites of volatile organic compounds as markers of 
exposure to vehicular and biomass fuel smoke.  
Cognition and Behaviour. We characterised a wide range of cognitive measures, 
such as executive control, emotion recognition, decision making, attention and impulsivity; 
behaviour and clinical phenotypes were indexed using the Mini International 
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Neuropsychiatric Interview (MINI) and Strengths and Difficulties Questionnaire (SDQ), as 
well as an extensive characterisation of behavioural measures related to externalising 
behaviour and psychopathology including substance use behavioural addictions, eating 
disorders and mobile phone use (Table 1).  
Key findings from the baseline study 
As the first overview of the study, here we present data on experiences of childhood 
adversity and psychopathology (Table 2). At baseline, overall 46.2% (n=4145) participants 
had experienced frequent (defined as many times) childhood adversity of any given type, a 
lower rate compared to 77.7% reported from ALSPAC (35). Overall, the most prevalent type 
of adversity in c-VEDA was living with an alcohol and drug abuser(s) in the same household 
(26.1%), while in ALSPAC parental psychopathology topped all childhood adversities 
(42.7%). Amongst the five types of childhood maltreatment assessed (emotional, physical, 
sexual abuse, emotional and physical neglect), emotional abuse was the most prevalent 
overall (9.4%), similar to IMAGEN (5.3%) and ALSPAC (19.3%). The seven study sites 
showed expected variation in adverse experiences recorded (Table 2), partly due to the 
different recruitment strategies applied in each site. For any adversity experienced, 
Chandigarh reported the highest rate of adverse experiences (60.3%) amongst all sites, and 
RV the lowest (26.6%). Five of the seven sites reported living with an alcohol and drug 
abuser(s) in the same household to be the most prevalent type of adversity (Bengaluru-
NIMHANS 89.4%, Mysuru 9.9%, Chandigarh 48.5%, Kolkata 17.8%, and RV 10.6%);  
emotional neglect was the most prevalent in Mysuru (12.5%), and community violence in 
Imphal (44.1%). Amongst all types of childhood maltreatment, three sites (Bengaluru-
NIMHANS 23.4%, Imphal 10.6%, and RV 3.6%) reported emotional abuse being the most 
prevalent, whereas emotional neglect was most prevalent in the remaining 4 sites (Bengaluru-
SJRI 12.5%, Mysuru 5.0%, Kolkata 5.4%, Chandigarh 6.6%).  
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At baseline, 3.3% of the participants reported experiencing current major depressive 
episode, 4.9% reported current anxiety disorders, and 3.5% reported current ADHD (Table 
2). Current alcohol and substance abuse/dependence were reported by 0.5% and 0.9% of 
participants respectively. Similar to childhood adversity, sites also reported varied rates in 
psychopathology (Table 2). We visualised behavioural and psychological outcomes assessed 
using the Strength & Difficulties Questionnaire alongside participants from ALSPAC. c-
VEDA participants exhibited a trend of scoring higher in all difficulties and prosocial 
behaviour before the age 14 (Figure2). Variations between those who live in urban versus 
rural areas, and those with and without experiences of childhood adversities are also 
presented in Figure 2. 
Strengths and Challenges 
Strength. The c-VEDA study offers for the first time a comprehensive 
neurobehavioural characterisation in a LMIC of a large number of children and adolescents, 
in addition to its inclusive environmental measures. Being the first and largest of its kind in 
India, c-VEDA can serve as a normative database of Indian children, adolescents and young 
adults for highly valuable investigations such as genome-wide association studies on 
psychiatric traits and generation of normative age-specific brain atlases within Indian 
population. Additionally, as each study site presents uniqueness in their sociocultural and 
environmental characteristics due to the wide-spread recruitment strategy, c-VEDA also 
enables direct comparisons between different groups within India, potentially addressing 
novel research questions.  
The study design permits three waves of data collection spanned a wide age to be 
achieved within short period of time, and the planned missingness design would allow 
parameters of interest to be estimated without bias. The rich longitudinal dataset based 
outside Western societies that’s comparable with many similar cohorts worldwide (e.g., the 
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Adolescent Brain Cognitive Development Study (36), and similar initiatives in China (9), 
IMAGEN, ALSPAC) provides unique opportunities to investigate sociocultural and 
biological foundation for the manifestation of externalizing disorders and addictions. For 
example, the investigation of the heterogeneity of developmental trajectories into 
externalising disorders in HICs and LMICs, and the bio-psycho-social mediators or 
moderators to these trajectories can shed light to the recently rising field of precision 
psychiatry and global mental health.  
Challenges. While the combination of sequential cohort and planned missing data 
design renders setting up cohort very efficient, it also poses some statistical challenges. First, 
the planned missing design randomised baseline participants into two groups to be followed 
up separately, meaning the traditional two-wave analysis (comparing the same group of 
people at baseline then follow-ups) would have reduced power. However, a variety of 
longitudinal models, either within a Structural Equation Modelling or Multilevel Modelling 
framework, can take full advantage of such data. For example, using a joint model one might 
examine the longitudinal interplay between alcohol use and antisocial behaviour through 
adolescence. In addition, these models, through their use of a maximum-likelihood approach 
to missing data, based on a Missing At Random assumption, can demonstrate a high level of 
statistical power for a fraction of the monetary and time costs of following all individuals for 
the whole time period. Notably, there will nevertheless be missing observations in either of 
the follow-ups that are not “planned” and likely to be missing at random (MAR). The 
Structural Equation Model Framework offers a number of maximum-likelihood (ML) based 
alternatives, such as full information ML (FIML) approach, which estimates a likelihood 
function for each individual based on variables present, and produces unbiased parameter 
estimates and standard errors (37, 38). Moreover, our study design has been rarely applied to 
neuroimaging data. Although limited knowledge exists for model fitting using neuroimaging 
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data of such structure, some suggested that mixed-longitudinal models with an autoregressive 
covariance structure modelling could be useful (39, 40).  
Another challenge is brought about by the relatively low consent/assent rate for MRI 
participation in the lower age band (6-11 years old) compared to the higher age bands (12-17, 
18-23 years old), and the low follow-up rate amongst neuroimaging subsample with 
particularly low rates amongst younger children, which may pose potential power issues 
when estimating effect sizes in complicated models. One must consider the missing data 
mechanism carefully above and beyond the planned missingness design, such as reasons for 
participants missing certain wave(s) of data or being excluded due to bad data quality, and it 
is recommended that sensitive analysis should be performed by fitting multiple models and 
examining the similarities of different estimates (41). 
Additionally, what also presents challenges for analysing c-VEDA data is the 
uniquely complex social/ethnic/religious background in India, which may be intertwined to 
have an impact on genetic population stratification (42). Study site in our study is potentially 
a confounding factor that has an influence on both genetics and environmental exposures. 
Various statistical analysis strategies can be applied to control for population stratification for 
both overall sample and for each study site, depending on the research question. For example, 
when investigating environmental influences on brain and behaviour collectively, besides 
controlling for site effects, one can also first examine environmental influences on brain and 
behaviour by site or within subgroups of similar genetic background regardless of site, 
followed up by meta-analysis to examine the overall effect. Alternatively, one can also 
control for genetic components extracted through e.g., Principal Component Analysis (PCA) 
to account for population stratification within sites to avoid false positive associations.  
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Data Access and Study Information 
More details on the consortium can be found at www.cveda.org. For data use and 
collaborations, please contact principal investigators Prof. Gunter Schumann 
(gunter.schumann@kcl.ac.uk) and Prof. Vivek Benegal (vbenegal@gmail.com) who will 
review the requests together with the consortium executive committee.   
c-VEDA data will be accessible to the wider scientific community in a sustained and 
secure manner, which offers ways of searching and querying specific data through an 
anonymised databank structure developed for the IMAGEN (43). Identical data are stored in 
both NIMHANS and IMAGEN databank. Data quality control SOP and reports on each data 
release can also be found at www.cveda.org. The full baseline data is expected to be made 
accessible in February 2020. Follow-ups’ data will be made available upon completion of 
both waves of follow-ups in October 2021, after identical QC and pre-processing procedures 
to baseline data being carried out.  
External researchers are invited to propose projects, which are discussed and 
approved by the scientific steering committee. For data access and sharing rules, please see 
Appendix 1. Upon approval of project proposals, it is recommended that proposal holders 
consult or work with a member of the consortium from India, who are more familiar with the 
socio-cultural specific aspects of the data that may not be familiar to researchers used to HIC 
data for example.  
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Fig. 1  
a c-VEDA study sites. 
1 Postgraduate Institute of Medical Education and Research (PGI); 2 Regional Institute of Medical 
Sciences (RIMS); 3 ICMR-Regional Occupational Health Centre (ROHC); 4 Rishi Valley Rural 
Health Centre (RVRHC); 5 National Institute of Mental Health and Neurosciences (NIMHANS); 6 
St. John’s Research Institute (SJRI); 7 CSI Holdsworth Memorial Mission Hospital (HMH); 8 Birth 
Cohort set up in collaboration with the MRC Life-course Epidemiology Unit, Southampton; * Sites 
recruited neuroimaging subsample. Site 4, 5, and 6 were all scanned at site 5 (Siemens Skyra, 
Philips Ingenia). Scanners used in site 1 3, 7 are Siemens Verio, Siemens Verio, and Philips Ingenia, 
respectively.  
b According to the accelerated longitudinal design,  c-VEDA recruited participants from a wide age 
range (6-23 years old) at baseline; the planned missingness design further randomized baseline 
participants into two groups, the first group would be followed up 1-year post-baseline, and the 
second group 2 years post-baseline assessment. 
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Fig. 2 
Strength & Difficulties Questionnaire subscale scores by age in c-VEDA versus ALSPAC, and 
amongst c-VEDA participants, those who live in urban areas versus rural areas, as well as those 
experienced no childhood adversity defined by the frequent scale of Adverse Childhood Experience 
Questionnaire, versus those experienced at least one type of childhood adversity For c-VEDA, 
parental reports were used for participants aged between 6 and 17, and self-reports were used for 
those between 18 and 23 years of age when generating this graph. ALSPAC used parental report 
only.
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Table 1. c-VEDA measurements by age band (C1=6-11, C2=12-17, C3=18-23 years old) and comparison with IMAGEN, ALSPAC and SCAMP 
  c-VEDA    
  Baseline 
Follow-up 
   
DOMAIN/Measurement Description  C1 C2 C3 IMAGEN ALSPAC SCAMP 
ENVIRONMENT         
- Adverse Childhood Experiences-
International Questionnaire  
Abuse, neglect, violence and any serious 
household dysfunction  
✓ ✓ ✓ S1 ✓ ✓  
- Alabama Parenting Questionnaire * Parenting behaviour ✓ ✓   ✓ ✓  
- Environmental Exposure Questionnaire Energy, drainage, pesticides, insecticides  ✓ ✓ ✓    ✓ 
- Family History Questionnaire  Family history of mental illness  ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
- Indian Family Violence and Control Scale  Abuse experiences of married women at the 
hands of their partners/marital family  
✓ ✓ ✓   ✓  
- Life Event Questionnaire * Major life events   ✓  ✓ ✓ ✓ 
- Pregnancy History Interview-Revised Pregnancy history, nutrition, complications ✓ ✓ ✓  ✓ ✓ ✓ 
- Parent Bonding Instrument  Parenting style   ✓   ✓  
- School Climate Questionnaire * Peers, bullying, school environment ✓ ✓ ✓   ✓ ✓ 
- Socio-demographic Information and 
Migration questions * 
Migration status ✓ ✓ ✓ ✓ ✓ ✓  
- Short Food Questionnaire-Revised Food intake & nutrition ✓ ✓ ✓   ✓  
- Usage of digital devices questionnaire 
adapted from SCAMP 
Screen exposure  ✓ ✓  ✓  ✓ 
NEUROIMAGING         
- Structural MRI – T1/T2  S S S S ✓ ✓  
- DTI  S S S S ✓ ✓  
- Functional MRI – Resting state fMRI  S S S S ✓ ✓  
PHYSICAL DEVELOPMENT & HEALTH 
- Anthropometry Height and Weight; mid arm & head 
circumference, leg length  
✓ ✓ ✓ S ✓ ✓ ✓ 
- Medical Problems Questionnaire  
 
Symptoms and diagnoses of physical 
conditions 
 
✓ ✓ ✓   ✓  
- Pubertal Development Scale  Pubertal development ✓ ✓  S ✓ ✓ ✓ 
BIOLOGICAL SAMPLE         
- Blood (or buccal swab) Genetic information ✓2 ✓2 ✓2 S ✓   
- Urine Neurotoxins ✓ ✓ ✓    ✓ 
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  c-VEDA    
  Baseline Follow-up    
DOMAIN/Measurement Description  C1 C2 C3  IMAGEN ALSPAC SCAMP 
COGNITION         
- Balloon Analogue Risk-Taking Task  Risk-taking behaviour ✓ ✓ ✓  ✓   
- Corsi Block Tapping Test (PEBL) Visual-spatial attention & working memory ✓ ✓ ✓  ✓ ✓ ✓ 
- Digit Span (PEBL) Verbal attention & working memory ✓ ✓ ✓  ✓ ✓ ✓ 
- Emotional Recognition Task Emotion recognition ✓ ✓ ✓   ✓  
- 27-item Monetary Choice Questionnaire 
(Now-or-later test) 
Reward processing & decision-making ✓ ✓ ✓  ✓   
- Social Cognition Rating Tools in the Indian 
Setting 
Theory of Mind ✓ ✓ ✓   ✓  
- Stop Signal Task  Response inhibition (Impulse control)  ✓ ✓ ✓  ✓ ✓  
- Trial Making Test (PEBL) Visual attention and task shifting  ✓ ✓ ✓  ✓ ✓ ✓ 
- Wisconsin Card Sorting Test (PEBL) Cognitive flexibility ✓ ✓ ✓     
BEHAVIOUR & PSYCHOPATHOLOGY         
- Alcohol, Smoking and Substance 
Involvement Screening Test * 
Substance use and related problems  ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
- Adult Temperament Questionnaire  Temperament and personality    ✓  ✓ ✓  
- Early Adolescent Temperament 
Questionnaire  
Temperament to social-emotional 
functioning  
 ✓   ✓ ✓  
- Adolescent Attachment Questionnaire Attachment to parents; caregiving 
experience  
 ✓   ✓ ✓  
- Big Five Personality Test * Five factors of personality   ✓  ✓   
- Childhood Behaviour Questionnaire Behavioural problems ✓     ✓  
- Mini-International Neuropsychiatric 
Interview * 
Clinical interview on psychiatric disorders  ✓ ✓ ✓ S    
- Strengths and Difficulties Questionnaire * Emotional symptoms, conduct problems, 
hyperactivity/ inattention, peer relationship 
problems, prosocial behaviour 
✓ ✓ ✓ ✓ ✓ ✓ ✓ 
N.B. * Shared core assessments amongst all GIGA cohorts.1 S=Neuroimaging subsample; 2 Saliva samples were collected only when blood samples were not 
available or possible;  
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Mysore Imphal Chandigarh Kolkata Rishi Valley 
 N=8999 n=1883 n=1018 n=1411 n=1120 n=1267 n=1524 n=776 
N neuroimaging subsample    - -    
Age (years)         
- Range 5.32-24.91 6.00-23.98 5.38-17.45 7.42-24.91 5.93-23.74 5.32-24.06 5.35-24.19 5.32-24.47 
- Mean (SD) 14.55 (4.61) 15.19 (4.18) 12.21 (1.66) 18.46 (3.03) 15.22 (4.72) 15.16 (5.13) 12.03 (4.23) 11.91 (4.17) 
- Missing [n (%)] 1 5 (0.06) 3 (0.2) 1 (0.1) 0 (0.0) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Sex         
- Female [n (%)] 4699 (52.2) 41.6 72.8 63.3 51.1 32.1 60.1 49.9 
- Male [n (%)] 4300 (47.8) 58.4 27.2 36.7 48.9 67.9 39.9 50.1 
Caste         
- General [n (%)] 3852 (42.8) 1021 (54.2) 239 (23.5) 555 (39.3) 675 (60.3) 881(69.5) 328 (21.5) 153 (19.7) 
- Other Backwards Class [n (%)] 1864 (20.7) 285 (15.1) 252 (24.8) 367 (26.0) 341 (30.4) 63 (5.0) 144 (9.4) 412 (53.1) 
- Scheduled Castes [n (%)] 1357 (15.1) 348 (18.5) 212 (20.8) 169 (12.0) 40 (3.6) 88 (6.9) 409 (26.8) 91 (11.7) 
- Scheduled Tribes [n (%)] 649 (7.2) 110 (5.8) 51 (5.0) 29 (2.1) 53 (4.7) 4 (0.3) 369 (24.2) 33 (4.3) 
- Other [n (%)] 618 (6.9) 55 (2.9) 168 (16.5) 271 (19.2) 1 (0.1) 38 (3.0) 1(0.1) 84 (10.8) 
- Missing 1 659 (7.4) 64 (3.4) 96 (9.4) 20 (1.4) 10 (0.9) 193 (15.2) 273 (17.9) 3 (0.4) 
Religion         
- Hindu [n (%)] 6150 (68.3) 1493 (79.3) 608 (59.7) 806 (57.1) 979 (87.4) 612 (48.3) 1003 (65.8) 649 (83.6) 
- Muslim [n (%)] 806 (9.0) 105 (5.6) 136 (13.4) 199 (14.1) 12 (1.1) 22 (1.7) 229 (15.0) 103 (13.3) 
- Sikh [n (%)] 397 (4.4) 2 (0.1) 0 (0.0) 1 (0.1) 0 (0.0) 384 (30.3) 10 (0.7) 0 (0.0)
- Christian [n (%)] 809 (9.0) 204 (10.8) 154 (15.1) 353 (25.0) 71 (6.3) 9 (0.7) 1 (0.1) 17 (2.2)
- Jain [n (%)] 14 (0.2) 2 (0.1) 7 (0.7) 3 (0.2) 0 (0.0) 2 (0.2) 0 (0.0) 0 (0.0)
- Buddhist [n (%)] 2 (0.01) 2 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
- Other [n (%)] 203 (2.3) 23 (1.2) 40 (3.9) 34 (2.4) 47 (4.2) 46 (3.6) 9 (0.6) 4 (0.5)
- Missing [n (%)] 1 618 (6.9) 52 (2.8) 73 (7.2) 15 (1.1) 11 (1.0) 192 (15.2) 272 (17.8) 3 (0.4) 
House ownership     
- Family’s Own [n (%)] 6183 (68.7) 886 (47.1) 445 (43.7) 1113 (78.9) 1017 (90.8) 869 (68.6) 1211 (79.5) 662(82.7) 
- Rented [n (%)] 2201 (24.5) 947 (50.3) 500 (49.1) 283 (20.1) 93 (8.3) 206 (16.3) 41 (2.7) 131 (16.9) 
- Missing [n (%)]1 615 (6.8) 50 (2.7) 73 (7.2) 15 (1.1) 10 (0.9) 192 (15.2) 272 (17.8) 3 (0.4) 
House location         
- Rural [n (%)] 3444 (38.3) 329 (17.5) 12 (1.2) 623 (44.2) 594 (53.0) 421 (33.2) 889 (58.3) 576 (74.2) 
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- Urban [n (%)] 4940 (54.9) 1504 (79.9) 933 (91.7) 773 (54.8) 516 (46.1) 654 (51.6) 363 (23.8) 197 (25.4) 
- Missing [n (%)]1 615 (6.8) 50 (2.7) 73 (7.2) 15 (1.1) 10 (0.9) 192 (15.2) 272 (17.8) 4 (0.4) 
Family structure     
- Nuclear (%) 6500 (72.2) 1708 (90.7) 612 (60.1) 1107 (78.5) 860 (76.8) 624 (49.3) 1130 (74.1) 459 (59.1) 
- Joined (%) 1825 (20.3) 122 (6.5) 288 (28.3) 288 (20.4) 250 (22.3) 448 (35.4) 115 (7.5) 314 (40.5) 
- Other 2 (%) 57 (0.6) 1 (0.1) 45 (4.4) 1 (0.1) 0 (0.0) 3 (0.4) 7 (0.5) 0 (0.0) 
- Missing [n (%)]1 617 (6.9) 52 (2.8) 73 (7.2) 15 (1.1) 10 (0.9) 192 (15.2) 272 (17.8) 3 (0.4) 
Life-time school enrolment 3 (%)     
- Yes [n (%)] 7812 (86.8) 1632 (86.7) 933 (91.7) 1333 (94.5) 1053 (94.0) 999 (78.8) 1135 (74.5) 727 (93.7) 
- No [n (%)] 562 (6.2) 200 (10.6) 12 (1.2) 63 (4.5) 57 (5.1) 75 (5.9) 109 (7.2) 46 (5.9) 
- Missing [n (%)]1 625 (6.9) 51 (2.7) 73 (7.2) 15 (1.1) 10 (0.9) 193 (15.2) 280 (18.4) 3 (0.4) 
Childhood Adverse experience 4     
- Type of adversities experienced [n (%)] 
o Emotional abuse  850 (9.4) 440 (23.4) 108 (10.6) 47 (3.3) 119 (10.6) 76 (6.0) 52 (3.4) 8 (1.0) 
o Physical abuse  540 (6.0) 273 (14.5) 77 (7.6) 32 (2.3) 64 (5.7) 59 (4.7) 27 (1.8) 8 (1.0) 
o Contact sexual abuse  58 (0.6) 20 (1.1) 0 (0.0) 6 (0.4) 1 (0.1) 14 (1.1) 17 (1.1) 0 (0.0) 
o Parental separation/absence 703 (7.8) 174 (9.2) 70 (6.9) 56 (4.0) 223 (19.9) 62 (4.9) 42 (2.8) 76 (9.8) 
o Domestic violence  1381 (15.3) 461 (24.5) 119 (11.7) 71 (5.0) 415 (37.1) 184 (14.5) 65 (4.3) 66 (8.5) 
o Emotional neglect  609 (6.8) 132 (7.0) 127 (12.5) 71 (5.0) 84 (7.5) 84 (6.6) 83 (5.4) 28 (3.6) 
o Physical neglect  256 (2.8) 98 (5.2) 7 (0.7) 17 (1.2) 43 (3.8) 50 (3.9) 20 (1.3) 21 (2.7) 
o Bullying 107 (1.2) 40 (2.1) 2 (0.2) 24 (1.7) 15 (1.3) 23 (1.8) 2 (0.1) 1 (0.1) 
o Community violence  947 (10.5) 140 (7.4) 55 (5.4) 119 (8.4) 494 (44.1) 86 (6.8) 18 (1.2) 35 (4.5) 
o War/collective violence  23 (0.3) 6 (0.3) 4 (0.4) 1 (0.1) 6 (0.5) 4 (0.3) 1 (0.1) 1 (0.1) 
o Alcohol/drug abuser in the 
household 2349 (26.1) 917 (89.4) 50 (4.9) 139 (9.9) 276 (24.6) 614 (48.5) 271 (17.8) 82 (10.6) 
o Household member mental 
illness 402 (4.5) 131 (7.0) 9 (0.9) 15 (1.1) 99 (8.8) 133 (10.5) 10 (0.7) 5 (0.6) 
o Household member 
imprisonment 141 (1.6) 29 (1.5) 11 (1.1) 5 (0.4) 55 (4.9) 19 (1.5) 11 (0.7) 11 (1.4) 
- Number of adversities experienced [n (%)] 
o 0 4149 (46.1) 610 (32.4) 583 (57.3) 1011 (71.7) 317 (28.3) 282 (22.3) 781 (51.2) 565 (72.8) 
o 1 2030 (22.6) 370 (19.6) 202 (19.8) 263 (18.6) 299 (26.7) 440 (34.7) 328 (21.5) 128 (16.5) 
o 2 991 (11.0) 375 (19.9) 87 (8.5) 68 (4.8) 212 (18.9) 148 (11.7) 55 (3.6) 46 (5.9) 
o 3 and more 1126 (12.5) 461 (24.1) 74 (7.3) 52 (3.8) 279 (25.0) 176 (13.9) 51 (3.5) 33 (4.2) 
o Missing 703 (7.8) 67 (3.6) 72 (7.1) 17 (1.2) 13 (1.2) 221 (17.4) 309 (20.3) 5 (0.5) 
- ACES score [Mean (SD)] 1.03 (1.45) 1.66 (1.73) 0.68 (1.11) 0.44 (0.94) 1.67 (1.64) 1.39 (1.47) 0.53 (0.99) 0.46 (0.99) 
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Strength and Difficulties Questionnaire 5 [Mean (SD)] 
- Emotional symptoms 3.28 (2.54) 2.31 (2.32) 3.59 (2.53) 3.88 (2.65) 4.12 (2.63) 3.04 (2.60) 3.94 (2.22) 2.40 (2.03) 
- Conduct problems 2.46 (1.94) 2.46 (1.89) 2.10 (1.43) 2.61 (2.00) 2.21 (1.58) 2.32 (2.16) 3.59 (2.02) 1.54 (1.74) 
- Hyperactivity/inattention 3.67 (2.21) 3.46 (2.11) 4.44 (1.73) 2.82 (1.94) 4.29 (2.30) 3.77 (2.45) 4.49 (1.86) 2.39 (2.23) 
- Peer problems 2.52 (1.85) 1.89 (1.89) 3.28 (1.52) 2.79 (1.76) 2.50 (1.73) 2.27 (1.90) 2.97 (1.81) 2.32 (1.85) 
- Prosocial behaviour 7.86 (2.37) 7.68 (3.30) 6.51 (1.98) 8.84 (1.59) 8.05 (1.85) 8.44 (1.67) 6.92 (2.05) 8.71 (1.70) 
Psychopathology 6         
- Alcohol abuse and/or 
dependence, current (%) 45 (0.5) 29 (1.5) 0 (0.0) 3 (0.2) 3 (0.3) 5 (0.4) 3 (0.2) 2 (0.3) 
- Substance abuse and/or 
dependence, current (%) 84 (0.9) 56 (3.0) 0 (0.0) 1 (0.1) 9 (0.8) 13 (1.0) 5 (0.3) 5 (0.6) 
- ADHD current (%) 7 316 (3.5) 154 (8.2) 7 (0.7) 10 (0.7) 19 (1.7) 70 (5.5) 27 (1.8) 29 (3.7) 
- Major depressive episode, 
current (%) 300 (3.3) 62 (3.3) 6 (0.6) 92 (6.5) 36 (3.2) 39 (3.1) 47 (3.1) 18 (2.3) 
- Anxiety disorders, current (%)8 444 (4.9) 93 (4.9) 40 (3.9) 145 (10.3) 44 (3.9) 57 (4.5) 25 (1.6) 40 (5.2) 
N.B. 1 Missing included “refused”, “don’t know”, and system missings; 2 This included: staying with grandparent(s), n=4; staying with relatives (e.g., grandparents, aunt, older 
sister), n=7; semi-nuclear family, n=1; staying in a hostel, n=20; living in orphanages, n=23; Staying with extended family, n=6; 3 This is assessed using the question “did the 
subject never enrol/discontinue/drop out of school or college”; 4 Adverse childhood experiences in c-VEDA are measured using the Adverse Childhood Experiences 
International Questionnaire, the frequency version; 5 Participants aged between 6 and 17 years old used parental report, and 19-23 used self-report; 6 Measured by the Mini 
International Neuropsychiatric Interview for Children and Adolescent (M.I.N.I KID; C1 and C2 age bands) and the Mini-International Neuropsychiatric Interview (M.I.N.I; C3 
age band); 7 Current ADHD in C3 age band is measured by the Adult ADHD Self-Report Scale; 8 Measured using M.I.N.I. KID and M.I.N.I., combining panic disorder-
lifetime, panic disorder-limited symptom attacks lifetime, panic disorder current, agoraphobia current without history of panic disorder, panic disorder without agoraphobia 
current, separation anxiety disorder (M.I.N.I KID only), social anxiety disorder current, obsessive-compulsive disorder current, and generalised anxiety disorder current; 
SD=Standard deviation. 
 
 
  


